Regeneron Pharmaceuticals マネジメント
マネジメント 基準チェック /44
Regeneron Pharmaceuticalsの CEO はLeonard Schleiferで、 Jan1988年に任命され、 の在任期間は 36.83年です。 の年間総報酬は$ 8.18Mで、 22.9%給与と77.1%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の2.23%を直接所有しており、その価値は$ 1.81B 。経営陣と取締役会の平均在任期間はそれぞれ7.2年と17.9年です。
主要情報
Leonard Schleifer
最高経営責任者
US$8.2m
報酬総額
| CEO給与比率 | 22.9% |
| CEO在任期間 | 36.8yrs |
| CEOの所有権 | 2.2% |
| 経営陣の平均在職期間 | 7.2yrs |
| 取締役会の平均在任期間 | 17.9yrs |
経営陣の近況
Recent updates
Regeneron: Buying A Promising Pipeline At A Fair Price (Rating Upgrade)
Nov 04Amgen Biosimilar And EYLEA Patent Dispute: What It Means For Regeneron Investors
Sep 25Is Regeneron Pharmaceuticals (NASDAQ:REGN) Using Too Much Debt?
Sep 09
Regeneron Stock: Valuation Now Demands More Growth
Aug 26Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Intrinsic Value Is Potentially 81% Above Its Share Price
Aug 22Risks To Shareholder Returns Are Elevated At These Prices For Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Aug 04Regeneron's Robust Pipeline And Financial Health Signal Continued Growth
Aug 02Regeneron: Downgrading My Outlook To 'Hold' Ahead Of Q2 Earnings
Jul 11Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) CEO Compensation Looks Acceptable To Us And Here's Why
Jun 08These 4 Measures Indicate That Regeneron Pharmaceuticals (NASDAQ:REGN) Is Using Debt Reasonably Well
May 21Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks
May 06Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Popularity With Investors Is Under Threat From Overpricing
Apr 30Is There An Opportunity With Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) 47% Undervaluation?
Apr 10Regeneron's Triple Threat: Eylea, Libtayo, And Dupixent Dominate
Mar 26Regeneron Pharmaceuticals' (NASDAQ:REGN) Conservative Accounting Might Explain Soft Earnings
Feb 16Regeneron Pharmaceuticals: Time To Change My Strategy After Encouraging Q4 2024
Feb 10CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$5b |
| Jun 30 2024 | n/a | n/a | US$4b |
| Mar 31 2024 | n/a | n/a | US$4b |
| Dec 31 2023 | US$8m | US$2m | US$4b |
| Sep 30 2023 | n/a | n/a | US$4b |
| Jun 30 2023 | n/a | n/a | US$4b |
| Mar 31 2023 | n/a | n/a | US$4b |
| Dec 31 2022 | US$7m | US$2m | US$4b |
| Sep 30 2022 | n/a | n/a | US$5b |
| Jun 30 2022 | n/a | n/a | US$6b |
| Mar 31 2022 | n/a | n/a | US$8b |
| Dec 31 2021 | US$6m | US$2m | US$8b |
| Sep 30 2021 | n/a | n/a | US$7b |
| Jun 30 2021 | n/a | n/a | US$6b |
| Mar 31 2021 | n/a | n/a | US$4b |
| Dec 31 2020 | US$135m | US$1m | US$4b |
| Sep 30 2020 | n/a | n/a | US$3b |
| Jun 30 2020 | n/a | n/a | US$3b |
| Mar 31 2020 | n/a | n/a | US$2b |
| Dec 31 2019 | US$21m | US$1m | US$2b |
| Sep 30 2019 | n/a | n/a | US$2b |
| Jun 30 2019 | n/a | n/a | US$2b |
| Mar 31 2019 | n/a | n/a | US$2b |
| Dec 31 2018 | US$27m | US$1m | US$2b |
| Sep 30 2018 | n/a | n/a | US$2b |
| Jun 30 2018 | n/a | n/a | US$2b |
| Mar 31 2018 | n/a | n/a | US$1b |
| Dec 31 2017 | US$27m | US$1m | US$1b |
報酬と市場: Leonardの 総報酬 ($USD 8.18M ) は、 US市場 ($USD 12.74M ) の同様の規模の企業の平均を下回っています。
報酬と収益: Leonardの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Leonard Schleifer (71 yo)
36.8yrs
在職期間
US$8,184,338
報酬
Dr. Leonard S. Schleifer, M.D., Ph D., Co-founded Regeneron Pharmaceuticals, Inc. in 1988 and has been its President and Chief Executive Officer since 1988 and is its Board Co-Chair since June 2023. He ser...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Co-Founder | 36.8yrs | US$8.18m | 2.23% $ 1.8b | |
| Co-Founder | 23.8yrs | US$7.76m | 1.07% $ 873.1m | |
| Executive Vice President of Research | 5.8yrs | US$8.43m | 0.048% $ 38.9m | |
| Executive VP and GM of Industrial Operations & Product Supply | 16.6yrs | US$8.76m | 0.031% $ 25.6m | |
| Senior VP of Finance & CFO | less than a year | データなし | 0.017% $ 14.2m | |
| Senior Vice President of Quality Assurance & Operations | 4.8yrs | データなし | データなし | |
| Senior VP of IT & Chief Information Officer | 3.8yrs | データなし | データなし | |
| Senior Vice President of Investor Relations & Strategic Analysis | no data | データなし | データなし | |
| Executive VP | 13.2yrs | US$7.13m | 0.036% $ 29.0m | |
| Senior VP & Chief Compliance Officer | 1.8yrs | データなし | データなし | |
| Senior Vice President of Corporate Affairs | no data | データなし | データなし | |
| Executive Vice President of Human Resources | 8.6yrs | データなし | データなし |
7.2yrs
平均在職期間
64.5yo
平均年齢
経験豊富な経営陣: REGNの経営陣は経験豊富で経験豊富です（平均在職期間は7.2年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Co-Founder | 36.8yrs | US$8.18m | 2.23% $ 1.8b | |
| Co-Founder | 23.8yrs | US$7.76m | 1.07% $ 873.1m | |
| Lead Independent Director | 14yrs | US$748.01k | 0.00073% $ 594.4k | |
| Independent Director | 21.8yrs | US$724.99k | 0.016% $ 13.3m | |
| Independent Director | 33.4yrs | US$728.99k | 0.012% $ 9.5m | |
| Independent Director | 33.4yrs | US$709.99k | 0.0046% $ 3.8m | |
| Independent Director | 36.8yrs | US$724.99k | 0.026% $ 21.5m | |
| Independent Director | 7.8yrs | US$704.99k | 0.000010% $ 8.1k | |
| Independent Director | 2.1yrs | US$247.79k | 0% $ 0 | |
| Independent Director | 8.2yrs | US$714.99k | 0% $ 0 | |
| Independent Director | 8.2yrs | US$709.99k | 0.0013% $ 1.0m | |
| Independent Director | 1.2yrs | US$1.03m | 0% $ 0 |
17.9yrs
平均在職期間
71yo
平均年齢
経験豊富なボード: REGNの 取締役会 は経験豊富で 経験豊富 です ( 17.9年の平均在任期間)。